ArticleCancer science2026
RETRACTION: Clinicopathological Significance of the MicroRNA-146a/WASP-Family Verprolin-Homologous Protein-2 Axis in Gastric Cancer.
Article in Cancer science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionQ. Yao, C. Tu, D. Lu, Y. Zou, H. Liu, and S. Zhang, "Clinicopathological Significance of the MicroRNA-146a/WASP-Family Verprolin-Homologous Protein-2 Axis in Gastric Cancer," Cancer Science 108, no. 7 (2017): 1285-1292, https://doi.org/10.1111/cas.13254. The above article, published online on 07 April 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed upon following concerns about the reliability of data and images raised by a third party. An investigation also identified duplication of images between Figures 2b and 2c. The authors did not respond to invitations to comment on these concerns nor provide supporting data to support the findings. The editors therefore consider the results and conclusions of this article unreliable. The authors did not respond to our notice of retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.